SCHEMBL29465604

SCHEMBL29465604

CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC[C@]1(C)CCc2cc(O)c(C)c(C)c2O1

nearest known ligand 0.83

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 14/20 0.83
PTGES O14684 1/20 0.69
PPARG P37231 3/20 0.59
PPARA Q07869 2/20 0.59
NR1I2 O75469 1/20 0.59
AKT1 P31749 2/20 0.56
PDPK1 O15530 1/20 0.56
PHLPP1 O60346 1/20 0.56
ILK Q13418 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gamma-Tocotrienol SCHEMBL16430897 1.00 ALOX5 (0.83) ALOX5PTGESPPARGPPARANR1I2
Gamma-Tocotrienol SCHEMBL3272929 1.00 ALOX5 (0.83) ALOX5PTGESPPARGPPARANR1I2
Gamma-Tocotrienol SCHEMBL3270920 1.00 ALOX5 (0.83) ALOX5PTGESPPARGPPARANR1I2
Gamma-Tocotrienol SCHEMBL3270923 1.00 ALOX5 (0.83) ALOX5PTGESPPARGPPARANR1I2
Gamma-Tocotrienol SCHEMBL29354672 1.00 ALOX5 (0.83) ALOX5PTGESPPARGPPARANR1I2
SCHEMBL17523133 0.93 ALOX5 (0.71) ALOX5PTGESPPARGPPARANR1I2
SCHEMBL12368109 0.93 ALOX5 (0.71) ALOX5PTGESPPARGPPARANR1I2
SCHEMBL18583914 0.93 ALOX5 (0.88) ALOX5PTGESPPARGPPARANR1I2
SCHEMBL18583915 0.91 ALOX5 (1.00) ALOX5PTGESPPARGPPARANR1I2
SCHEMBL16589599 0.90 ALOX5 (0.68) ALOX5PTGESPPARGPPARANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132413-A1 AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME WISCONSIN ALUMNI RES FOUNDATION (US) 2026-05-14 US disclosed
EP-4652287-A1 INFLUENCE OF RDDM PATHWAY VARIANTS ON MSH1 GRAFT OUTCOMES The Penn State Research Foundation (US) 2025-11-26 EP disclosed
US-12378567-B2 Arogenate dehydrogenase polynucleotides, polypeptides and methods of using the same WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2025-08-05 US disclosed
US-20250108036-A1 COMPOSITIONS FOR REMOVING SENESCENT CELLS AND USES THEREOF LIFECEUTIX CO., LTD. (KR) 2025-04-03 US disclosed
WO-2025061828-A1 STORAGE-STABLE COLD-PRESSED FLAXSEED OIL UNIVERSITAET WIEN (AT) 2025-03-27 WO disclosed
CN-119111649-A Processing method for removing bitter and fishy smell of linseed oil and efficiently retaining antioxidant nutrient linolenic phenol and grease processed by processing method 中粮营养健康研究院有限公司 2024-12-13 CN disclosed
CN-119081761-A Linseed oil with high content of antioxidant nutrient, namely linolenic acid and no bitter taste and preparation method of linseed oil 中粮营养健康研究院有限公司 2024-12-06 CN disclosed
WO-2024242988-A1 DEVELOPMENT AND APPLICATION OF SYNTHETIC INHIBITORS OF PHOTOSYNTHESIS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-11-28 WO disclosed
WO-2024226935-A1 INFLUENCE OF RDDM PATHWAY VARIANTS ON MSH1 GRAFT OUTCOMES THE PENN STATE RESEARCH FOUNDATION (US) 2024-10-31 WO disclosed
US-12006506-B2 Methods and compositions for obtaining useful plant traits NUTECH VENTURES (US) 2024-06-11 US disclosed
US-20230293423-A1 ANTIOXIDANT COMPOSITIONS AND METHODS OF PROTECTING SKIN, HAIR AND NAILS AGAINST HIGH ENERGY BLUE-VIOLET LIGHT PETKOSKA ANKA T (MK) 2023-09-21 US disclosed
EP-2853598-B1 Methods and compositions for obtaining useful plant traits UNIV NEBRASKA (US) 2023-09-13 EP disclosed
US-11576853-B2 Antioxidant compositions and methods of protecting skin, hair and nails against high energy blue-violet light CSI: Create.Solve. Innovate. LLC (US) 2023-02-14 US disclosed
US-20220387534-A1 ANTIOXIDANT AND ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEM TO PROTECT SKIN OR TREAT OR PREVENT INFECTIONS PETKOSKA ANKA T (MK) 2022-12-08 US disclosed
EP-3964536-A1 POLYOXAZOLIDINONE INTERMEDIATE CONTAINING AN ANTIOXIDANT BASF SE (DE) 2022-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132413-A1 AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME PNP, RNGTT, DPYD ALOX5 1807/4885PTGES 857/4885PPARG 2942/4885
US-20250108036-A1 COMPOSITIONS FOR REMOVING SENESCENT CELLS AND USES THEREOF GLA, LIMS1, TP53 ALOX5 227/4885PTGES 2034/4885PPARG 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.